Free Trial

Veradigm (NASDAQ:MDRX) Hits New 1-Year Low - Here's Why

Veradigm logo with Business Services background

Key Points

  • Veradigm Inc. (NASDAQ:MDRX) shares reached a new 52-week low of $3.00 during trading, closing at $4.65.
  • Wall Street Zen has initiated coverage with a "hold" rating, indicating cautious optimism regarding the company's future performance.
  • Veradigm provides healthcare technology solutions such as electronic health records and analytics services for organizations in various countries.
  • MarketBeat previews top five stocks to own in October.

Shares of Veradigm Inc. (NASDAQ:MDRX - Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $3.00 and last traded at $4.65, with a volume of 1594 shares trading hands. The stock had previously closed at $4.60.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on shares of Veradigm in a report on Tuesday, May 20th. They set a "hold" rating for the company. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $13.00.

View Our Latest Stock Report on Veradigm

Veradigm Stock Performance

The business has a 50-day moving average of $4.69 and a two-hundred day moving average of $4.61.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.